1. Frequency of antithyroid antibodies in patients with primary biliary cholangitis
    Mariam Ghozzi et al, 2024, Laboratory Medicine CrossRef
  2. Exome sequencing to explore the possibility of predicting genetic susceptibility to the joint occurrence of polycystic ovary syndrome and Hashimoto’s thyroiditis
    Natalia Zeber-Lubecka et al, 2023, Frontiers in Immunology CrossRef
  3. Alteration in gut microbiota is associated with immune imbalance in Graves’ disease
    Yalei Liu et al, 2024, Frontiers in Cellular and Infection Microbiology CrossRef
  4. Possible molecular exploration of herbal pair Haizao-Kunbu in the treatment of Graves’ disease by network pharmacology, molecular docking, and molecular dynamic analysis
    Mengfei Yang et al, 2023, Frontiers in Endocrinology CrossRef
  5. Circular RNA circPHF16 enhances IL-17A expression and secretion by sequestering miR-378a-3p to activate the IL6ST axis in Graves’ disease
    Zhengrong Jiang et al, 2024, Cytokine CrossRef
  6. Exposure to mixed chemicals elevated triiodothyronine (T3) and follicle-stimulating hormone (FSH) levels: epidemiology and in silico toxicogenomic involvement
    Hai Duc Nguyen, 2023, Environmental Science and Pollution Research CrossRef
  7. Nrf2, gp91phox and IL-17 are associated with severity and clinical outcomes of patients with subclinical hypothyroidism: a comparative study
    Jing Wang et al, 2024, Scandinavian Journal of Clinical and Laboratory Investigation CrossRef